Epigenome drug approved after setback

被引：0

|

作者：

不详

机构：

来源：

NATURE BIOTECHNOLOGY | 2015年 / 33卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：437 / 437

页数：1

相关论文

共 50 条

[1] Epigenome drug approved after setback
Nature Biotechnology, 2015, 33 (5) : 437 - 437
[2] Lupus Drug Is Approved Despite Previous Clinical Trial Setback
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (11): : 1000 - 1000
[3] BASILEA LICENSES A DRUG AFTER SETBACK
不详
CHEMICAL & ENGINEERING NEWS, 2010, 88 (09) : 25 - 25
[4] AFFYMAX CUTS JOBS AFTER DRUG SETBACK
不详
CHEMICAL & ENGINEERING NEWS, 2013, 91 (12) : 23 - 23
[5] SYNERGEN STOCK PLUNGES AFTER DRUG TRIAL SETBACK
THAYER, A
CHEMICAL & ENGINEERING NEWS, 1993, 71 (09) : 7 - 7
[6] SETBACK FOR ANTICANCER DRUG
不详
CHEMISTRY IN BRITAIN, 1995, 31 (04) : 286 - 286
[7] Another Duchenne drug setback
Jarvis, Lisa
CHEMICAL & ENGINEERING NEWS, 2016, 94 (09) : 14 - 14
[8] Setback for personalised drug regimes
Cohen, P
NEW SCIENTIST, 1997, 153 (2071) : 10 - 10
[9] Setback for Zeneca oral asthma drug
不详
EUROPEAN CHEMICAL NEWS, 1996, 65 (1698): : 31 - 31
[10] Drug approved for pain relief after dog knee surgery
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 249 (08): : 852 - 852

← 1 2 3 4 5 →